Urokinase and Intraventricular Hemorrhage (IVH)


Phase N/A Results

Summary of Purpose

To assess whether intraventricular urokinase administered in conjunction with external ventricular drainage (EVD) leads to a lower mortality rate than is seen with EVD alone in patients with intraventricular hemorrhage (IVH).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 June 2002.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



  • National Stroke Association, US Food and Drug Administration Orphan Drug Program

Trial Design

Part I: Non-randomized, non-controlled, prospective study. Part II: Randomized, controlled, double-blinded study.


  • Daniel F. Hanley, MD Division of Neurosciences Critical Care, Meyer 8-140 Johns Hopkins Medical Institutions 600 N Wolfe St Baltimore, MD 21287-7840